Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Meloxicam
Aspen Pharma Pty Ltd
Medicine Registered
MOVALIS CAPSULES- Product Information Page 1 of 18 MOVALIS CAPSULES PRODUCT INFORMATION NAME OF THE MEDICINE Meloxicam. The chemical names of meloxicam are 4-hydroxy-2-methyl-N-(5-methyl-2- thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide and 2H-1,2-benzothiazine-3- carboxamide,4-hydroxy-2-methy-N-(5-methyl-2-thiazolyl)-,1,1-dioxide. The molecular formula of meloxicam is C 14 H 13 N 3 O 4 S 2 , the molecular weight is 351.4, and the CAS number is 71125-38-7. The structural formula of meloxicam is: DESCRIPTION Meloxicam is a pastel yellow solid with pKa values of 1.09 and 4.18 and a melting point of about 256°C. The substance is practically insoluble in water, soluble in dimethylformamide, slightly soluble in chloroform and acetone, and very slightly soluble in methanol. There are no chiral centres and no polymorphs are formed under normal conditions. MOVALIS is available as capsules. The list of excipients for the capsules is provided below: Capsules (7.5 mg and 15 mg): sodium citrate, lactose, maize starch, magnesium stearate, gelatin, indigo carmine CI73015, iron oxide yellow CI77492, titanium dioxide, purified water. PHARMACOLOGY MOVALIS is a non-steroidal anti-inflammatory drug (NSAID) of the enolic acid class, which has shown anti-inflammatory, analgesic and antipyretic properties in animals. Meloxicam showed anti-inflammatory activity in all standard models of inflammation. A common mechanism for the above effects may exist in the ability of meloxicam to inhibit the biosynthesis of prostaglandins, known mediators of inflammation, by inhibition of cyclooxygenase (COX). MOVALIS- Product Information Page 2 of 18 Comparison of the ulcerogenic dose and Read the complete document